BANK VONTOBEL/CALL/ZOETIS/165/0.1/20.12.24

BANK VONTOBEL/CALL/ZOETIS/165/0.1/20.12.24 Stock

DE000VD3LQS8

Market Closed - Bid/Ask 01:40:33 2024-06-06 pm EDT			Pre-market 02:04:24 am
2.27 ^EUR	-1.30%		2.36	+3.96%

Current month	+26.82%
1 month	+26.11%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ZOETIS INC.

Chart BANK VONTOBEL/CALL/ZOETIS/165/0.1/20.12.24

Latest news about ZOETIS INC.

Zoetis : Stifel 2024 Jaws and Paws Conference (Transcript)	Jun. 06	PU
Zoetis : William Blair 44th Annual Growth Stock Conference (Transcript)	Jun. 06	PU
Zoetis Releases 2023 Sustainability Report to Share Progress in Building a Better Future for Communities, Animals and the Planet	Jun. 05	BU
Transcript : Zoetis Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 02:40 PM	Jun. 04

More news

Quotes 5-day view

Date	Price	Change
24-06-06	2.27	-1.30%
24-06-05	2.3	+16.75%
24-06-04	1.97	-2.48%
24-06-03	2.02	+12.85%
24-05-31	1.79	-6.28%

Real-time Boerse Frankfurt Warrants

Last update June 06, 2024 at 01:40 pm EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	ZOETIS INC.
Issuer	Vontobel
WKN	VD3LQS
ISIN	DE000VD3LQS8
Date issued	2024-04-05
Strike	165 $
Maturity	2024-12-20 (197 Days)
Parity	10 : 1
Emission price	1.74 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	2.33 €
Lowest since issue	0.85 €
Spread	0.02 €
Spread %	0.86%

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.

Sector

More about the company